AMICUS THERAPEUTICS, INC.·4

Jan 24, 5:20 PM ET

Crowley John F 4

4 · AMICUS THERAPEUTICS, INC. · Filed Jan 24, 2024

Insider Transaction Report

Form 4
Period: 2024-01-22
Crowley John F
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2024-01-22$12.36/sh55,327$683,958782,452 total
Holdings
  • Common Stock

    (indirect: By Trust)
    64,895
Footnotes (1)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.10 to $12.57 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4